InvestorsHub Logo
Followers 5
Posts 1006
Boards Moderated 0
Alias Born 04/17/2008

Re: sulaco post# 131482

Monday, 07/08/2013 7:13:42 AM

Monday, July 08, 2013 7:13:42 AM

Post# of 345868
""Peregrine Pharmaceuticals (NASDAQ: PPHM ) is an upstart biotech targeting the treatment and diagnosis of cancer through monoclonal antibodies. It has a potential winner in its lead candidate that will begin its telltale phase 3 clinical trial later this year.""
Upstart? Hardly.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News